Skip to content

DOKTER JORIS STUBBE

Active
Private limited companyfounded 2007active for 19 yearsLeon Spilliaertstraat 35, 8400 Oostende, BelgiumKBO/BCE: BE 0890.820.680

From the official registers: KBO 18 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

DOKTER JORIS STUBBE has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €718,512 and a net result of €89,803. Equity has been stable since 2019 (±1.7% per year). Its solvency ranks better than 82% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 05-07-2007 Normal situation
Legal form
Private limited company
Registered office
Leon Spilliaertstraat 35, 8400 Oostende
Activity
Specialist medical practice NACE 86220and 1 other
Establishment unit
2.231.394.730 8400 Oostende, since 17-02-2014
Financial year end
31 March
Peppol
Reachable since 15-12-2025

Board and ownership

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 31-03-2025
Gross margin
€154,575
▼ 14.5%
Turnover
≈ €290,000
estimated
Profit
€89,803
▼ 19.6%
Equity
€718,512
▲ 14.3%
Total assets
€810,632
▲ 3.3%
Staff
≈ 0.1 FTE
estimated
2026 accounts not filed, 1 day past the deadline
Filed on 31-10-2025PDF
Score breakdownraises riskFigures for financial year 2025 (filed on 07-11-2025)lowers riskLiquidity: current ratio 9.71, cash €221,805Sector: Human health activities (NACE 86)Equity €718,512 (88.6% of total assets)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 59% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 88.6% of total assets
Liquidity 84-4
short-term debt 5.7% · cash 27.4%
Profitability 83-4
return on assets 11.1%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1%highest value 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025lowest value 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026lowest value 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €65,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 9.71 (5.2 in 2024), above the usual 1.5. Short-term debt is 5.7% and cash 27.4% of total assets. 11.4% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 67% on liquidity, 31% on profitability and 58% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 9.71, cash €221,805
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Equity €718,512 (88.6% of total assets)
NBB · annual accounts
raises risk · Figures for financial year 2025 (filed on 07-11-2025)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 31-10-2025, 0 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2026
not filed
2025
on the day
2024
7 days early
2023
on the day
2022
3 days early
2021
67 days late
2020
39 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 6 accounts on average 16 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: More equity than 88% of companies in human healthsector median €124,628 · 20,680 companies €718,512 View

Documents

Annual accounts at the NBB

All 18 annual accounts

Articles and registers

Key facts about DOKTER JORIS STUBBE

What is the company number of DOKTER JORIS STUBBE?
The company number of DOKTER JORIS STUBBE is 0890.820.680. The VAT number is the same number with BE in front: BE 0890.820.680.
Where is DOKTER JORIS STUBBE based?
The registered office is at Leon Spilliaertstraat 35, 8400 Oostende.Company details
What does DOKTER JORIS STUBBE do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DOKTER JORIS STUBBE?
The legal form of DOKTER JORIS STUBBE is Private limited company (BV).
When was DOKTER JORIS STUBBE founded?
DOKTER JORIS STUBBE was founded on 05-07-2007.
Is DOKTER JORIS STUBBE still active?
Yes, DOKTER JORIS STUBBE is an active enterprise in the KBO register.
How many employees does DOKTER JORIS STUBBE have?
DOKTER JORIS STUBBE had an average of 0.2 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
What is the turnover of DOKTER JORIS STUBBE?
The turnover in financial year 2025 is ≈ €290,000. This figure is estimated from the gross margin of €154,575 and 43 comparable companies (NACE 86220). It probably lies between €240,000 and €380,000.
Is DOKTER JORIS STUBBE profitable?
In financial year 2025, DOKTER JORIS STUBBE made a profit of €89,803.
Where can I find the annual accounts of DOKTER JORIS STUBBE?
DOKTER JORIS STUBBE filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)

Comparable companies

These companies have the same main activity as DOKTER JORIS STUBBE: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €706,000 and €918,000, founded between 2007 and 2009.

CompanyTotal assetsGross margin
DOKTER JORIS STUBBE Oostende€810,632€154,575
DOKTER BEATRICE VALCK Oostende€863,039€161,826
PATKAT Wingene€889,418€157,692
DOKTER ISABEL HUTSEBAUT Damme€706,347€153,072
DR. DECOO DANNY Beernem€918,312€148,580
BURRINI-HERMAN Frasnes-lez-Anvaing€787,194€153,811
Dr. D. Ballaux Endocrinologie Aartselaar€828,754€163,535
Full comparison

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.